SALT LAKE CITY, July 17, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a pacesetter in genetic testing and precision medication, at the moment introduced outcomes from its nationwide Most cancers Threat Survey: Breast Most cancers Version, which revealed {that a} majority (63%) of girls have no idea that there’s an elevated threat of breast most cancers for ladies with dense breasts. The survey, now in its third yr, targeted on understanding the position of breast density and most cancers threat amongst ladies ages 18+ within the U.S. Key survey takeaways embrace:
44% of girls do not perceive breast density and 63% of girls do not know there’s a connection between breast density and most cancers threat.
Although dense breast tissue is regular, ladies who’ve it are at a barely elevated threat for growing breast most cancers.1 In response to new FDA tips, by September 2024 all breast imaging services should alert sufferers by letter if they’ve dense breasts offering suggestions that they contact their care supplier for follow-up and threat evaluation.2 For ladies with dense breasts, further screening strategies resembling ultrasound or MRI could also be really useful along with mammography to enhance most cancers detection charges.
“Dense breasts current distinctive challenges in breast most cancers screening, however consciousness and proactive administration may also help mitigate these challenges,” stated Dr. Ifeyinwa Stitt, an OB-GYN doctor in Annapolis, MD. “By understanding their breast density and most cancers threat, ladies could make knowledgeable choices about their screening choices and take proactive steps to prioritize their well-being.”
Solely 66% of girls consider that annual breast well being checks are vital.
The survey revealed that 92% of girls perceive that detecting most cancers early means they could have extra remedy choices and the next probability for higher outcomes. Regardless of this understanding, solely 66% ladies consider annual breast well being checks are vital.
“Discovering breast most cancers early is crucial, as early detection can result in improved affected person outcomes,” stated Edie Smith DNP, an Superior Apply Nurse and Myriad hereditary and breast most cancers material professional. “However we all know that dense breast tissue makes cancers tougher to detect with mammography alone. The fibrous and glandular tissue related to dense breasts seem white on a mammogram, simply as most cancers does. Nevertheless, mammography continues to be the one method to decide when you’ve got dense breasts.”
40% of girls assume they need to obtain further screenings, like MRIs or ultrasounds, if they’re recognized to have dense breast tissue, however only one/3 of these would take into account genetic testing.
These findings expose a crucial hole in understanding, as insights gathered by means of genetic testing might reveal sufferers at elevated threat that might profit from further screenings to determine most cancers at its earliest, most treatable stage. By combining genetic insights, household historical past and different scientific components like breast density, MyRisk® Hereditary Most cancers Check with RiskScore® calculates a lady’s 5-year and remaining lifetime threat of breast most cancers. If a lady is discovered to be at excessive threat, she then has a number of choices accessible to her, together with a change in medical administration.
“Breast most cancers has impacted my household since earlier than I used to be born – my nice grandmother, grandmother and mom all handed away from breast most cancers. My mom misplaced her battle at solely 42, after I was solely 21-years previous,” stated Ashley Dedmon, a affected person advocate for Myriad’s MyRisk with RiskScore take a look at. “I need each clinician within the nation who might not assume genetic testing is important to listen to my story. Your sufferers need and want this screening.”
In regards to the survey
Myriad Genetics Most cancers Threat Survey is a nationwide ballot carried out on-line by ACUPOLL Precision Analysis, Inc. from April 17-April 19, 2024, amongst a statistically consultant pattern (n=n=1,192) of U.S. females age 18+. The margin of error in survey outcomes for the entire base inhabitants at a 95% confidence interval is +/- 3%.
About MyRisk® Hereditary Most cancers Check with RiskScore®
MyRisk® with RiskScore® evaluates 48 genes related to hereditary most cancers threat to determine genetic modifications related to an elevated most cancers threat for 11 completely different cancers. When mixed with household historical past and different scientific components resembling breast density, MyRisk with RiskScore supplies eligible sufferers with a breast most cancers threat evaluation individualized to them.
About Myriad Genetics
Myriad Genetics is a number one genetic testing and precision medication firm devoted to advancing well being and well-being for all. Myriad develops and provides genetic exams that assist assess the danger of growing illness or illness development and information remedy choices throughout medical specialties the place genetic insights can considerably enhance affected person care and decrease healthcare prices. For extra info, go to www.myriad.com.
Secure Harbor Assertion
This press launch comprises “forward-looking statements” throughout the which means of the Non-public Securities Litigation Reform Act of 1995, together with statements regarding how genetic testing, when mixed with household historical past and different scientific components resembling breast density, might assist sufferers at elevated threat of breast most cancers who might profit from further screenings determine most cancers at its earliest and most treatable stage and the way a ladies’s understanding of their breast density and most cancers threat may also help them take a proactive and knowledgeable method because it pertains to their breast most cancers screening choices. These “forward-looking statements” are administration’s expectations of future occasions as of the date hereof and are topic to identified and unknown dangers and uncertainties that would trigger precise outcomes, situations, and occasions to vary materially and adversely from these anticipated. Such components embrace these dangers described within the firm’s filings with the U.S. Securities and Trade Fee, together with the corporate’s Annual Report on Type 10-Ok filed on February 28, 2024, in addition to any updates to these threat components filed on occasion within the firm’s Quarterly Studies on Type 10-Q or Present Studies on Type 8-Ok. Myriad shouldn’t be beneath any obligation, and it expressly disclaims any obligation, to replace or alter any forward-looking statements, whether or not on account of new info, future occasions or in any other case besides as required by regulation.
- Fibroglandular Density: What Are Dense Breasts? Breastcancer.org. Retrieved Might 30, 2024, from https://www.breastcancer.org/threat/risk-factors/dense-breasts
- Workplace of the Commissioner. (2023, March 9). FDA updates mammography rules to require reporting of breast density info and improve facility oversight. U.S. Meals And Drug Administration. https://www.fda.gov/news-events/press-announcements/fda-updates-mammography-regulations-require-reporting-breast-density-information-and-enhance
Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com
Media Contact
Glenn Farrell
(385) 318-3718
PR@myriad.com
